It is reported that high HDAC6 expression was an independent, poor prognostic factor in renal cell carcinoma (RCC) patients, and HDAC6 are considered to be a biomarker of RCCs prognostic and an indicator for RCC progression [52]. The gene discussed is HDAC6; the disease is renal cell carcinoma.